APA (7th ed.) Citation

Merkt, W., Röhrich, M., Mavriopoulou, E., Stütz, A. N., Distler, J. H. W., Schmitt, A., . . . Lorenz, H. (2025). Persisting CD19.CAR-T cells in combination with nintedanib: Clinical response in a patient with systemic sclerosis-associated pulmonary fibrosis after 2 years. The lancet. Respiratory medicine, 13(7), . https://doi.org/10.1016/S2213-2600(25)00159-6

Chicago Style (17th ed.) Citation

Merkt, Wolfgang, et al. "Persisting CD19.CAR-T Cells in Combination with Nintedanib: Clinical Response in a Patient with Systemic Sclerosis-associated Pulmonary Fibrosis After 2 Years." The Lancet. Respiratory Medicine 13, no. 7 (2025). https://doi.org/10.1016/S2213-2600(25)00159-6.

MLA (9th ed.) Citation

Merkt, Wolfgang, et al. "Persisting CD19.CAR-T Cells in Combination with Nintedanib: Clinical Response in a Patient with Systemic Sclerosis-associated Pulmonary Fibrosis After 2 Years." The Lancet. Respiratory Medicine, vol. 13, no. 7, 2025, https://doi.org/10.1016/S2213-2600(25)00159-6.